Results 281 to 290 of about 262,938 (292)

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

Lancet, The, 2014
Anne Corbett, Rohit Dhall, Clive Ballard
exaly  

Parkinson's Disease

New England Journal of Medicine, 1998
Anthony E Lang
exaly  

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2017
Dilan S Athauda, Simon S Skene, Nigel H Greig   +2 more
exaly  

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

Lancet, The, 2005
William C Nichols, Nathan D Pankratz, Francis Walker   +2 more
exaly  

Parkinson’s Disease

2014
openaire   +1 more source

Parkinson's Disease

JAMA, 1960
openaire   +2 more sources

Parkinson's Disease

Seminars in Neurology, 1966
openaire   +1 more source

Biogen and Amicus to pursue genetically validated Parkinson's disease target

Nature Reviews Drug Discovery, 2013
exaly  

Parkinson disease

Journal of the American Academy of Physician Assistants, 2012
openaire   +2 more sources

Neurostimulation for Parkinson's Disease with Early Motor Complications

New England Journal of Medicine, 2013
exaly